Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01). - Ishigaki K; Nakai Y; Kashiwabara K; Fujishiro M; Gotohda N; Toyama H; Maeda A; Shimizu Y; Miyamoto A; Takahashi A; Morinaga S; Yanagibashi H; et al. (Journal of gastroenterology, 2026)